Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

Bibliographic details

Authors

D. Morrone, C. Chen, L. Dinshaw, W. Jiang, Y. H. Kim, P. Kirchhof, Y. Koretsune, Ladislav Pecen, P. E. Reimitz, C. C. Wang, T. Yamashita, M. Unverdorben, R. De Caterina

Publication year

2021

Publication type

Abstrakt

Periodical

European Heart Journal

Bibliographic citation

MORRONE, D., CHEN, C., DINSHAW, L., JIANG, W., KIM, Y. H., KIRCHHOF, P., KORETSUNE, Y., PECEN, Ladislav, REIMITZ, P. E., WANG, C. C., YAMASHITA, T., UNVERDORBEN, M., DE CATERINA, R. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program. European Heart Journal. 2021, 42(Suppl. 1), 2980-2980. ISSN 0195-668X. E-ISSN 1522-9645
Dostupné z: doi:10.1093/eurheartj/ehab724.2980

DOI

10.1093/eurheartj/ehab724.2980

ID

550068